FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:116-118 July 14, 1994 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Non-Hodgkin's lymphomas are a heterogeneous group of disorders. Approximately 85 percent of them originate from B lymphocytes, and these B-cell lymphomas fall into the following main groups: lymphocytic lymphoma, follicular-center-cell lymphoma, mantle-cell lymphoma, diffuse large-cell lymphoma, and Burkitt's lymphoma. The mucosa-associated lymphoid-tissue (MALT) lymphomas, which occur in mucosal sites such as the stomach, form a separate category and may have a large-cell morphology. Of these various types, about 40 percent are diffuse large-cell lymphomas. In addition to distinctive cell-surface markers, there are characteristic genetic abnormalities in some kinds of lymphoma (Figure 1). These genetic disturbances often follow breakage . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Akasaka, T., Ueda, C., Kurata, M., Akasaka, H., Yamabe, H., Uchiyama, T., Ohno, H. (2000). Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood 96: 2907-2909 [Abstract] [Full Text]  
• Mooi, W. J., Kluin, P. M., Offit, K., Chaganti, R.S.K. (1994). The Advantage of Rearranging bcl-6. NEJM 331: 1459-1460 [Full Text]